atai Life Sciences announced a transition in its leadership. Florian Brand, Co-Founder and current CEO, will step down as CEO by the end of this year. Co-Founder Srinivas Rao, currently the Chief Scientific Officer, will be promoted to Co-CEO effective June 1, and intends to assume the role of CEO by the end of the year subject to appointment as required by local law. Rao brings over 24 years of knowledge and experience from diverse biotechnology and pharmaceutical roles, having held the titles of Chief Scientific, Medical, or Executive Officer at companies ranging from venture-backed startups to vertically integrated, publicly traded pharmaceutical companies.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATAI:
- Atai Life Sciences N.V. (ATAI) Q1 Earnings Cheat Sheet
- Here’s What You Missed in Cannabis, Psychedelics This Week
- Atai Life announces dosing of first patient in Phase 2a study of BPL-003
- atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
- Rising High: Exclusive talk with cannabis market research firm BDSA